Baker Bros. Advisors Lp bought $24.5M of Madrigal Pharmaceuticals (MDGL)
Executed Aug 18 2025, disclosed Aug 20 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 20 2025), the stock returned +15.8% (delay-adjusted); from the execution session (Aug 18 2025), +20.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Baker Bros. Advisors Lp (Other) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 1 sale), most often in Kodiak Sciences Inc. (KOD). Across 7 priced purchase filings, the average 21-session return was +27.3% from execution and +5.7% from disclosure (delay-adjusted; derived). The largest single filing was $317.8M of CELC (3,100,000 sh across 2 lots, as filed), executed Jul 14.
Healthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→91,806 sh across 5 lots
Exec Nov 4
Filed Nov 6 · 5:30 PM ET MDGLPURCHASE Madrigal Pharmaceuticals, Inc. $36.7M
96,519 sh across 22 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 6:12 PM ET